Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HMNF
2201
DELISTED
HMN Financial Inc
HMNF
| $1.48M | ﹤0.01% |
78,725
-3,171
| -4% | -$58.8K |
|
|
YMAB
2202
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.47M | ﹤0.01% |
216,200
+128,800
| +147% | +$965K |
|
|
IBDP
2203
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $1.47M | ﹤0.01% |
59,500
-16,880
| -22% | -$415K |
|
2204
Tapestry
TPR
$31.2B
| $1.46M | ﹤0.01% |
+34,200
| New | +$1.42M |
|
2205
SelectQuote
SLQT
$137M
| $1.46M | ﹤0.01% |
749,786
-698,513
| -48% | -$1.18M |
|
2206
Applovin
APP
$136B
| $1.46M | ﹤0.01% |
56,600
-1,057,400
| -95% | -$21.8M |
|
|
INN
2207
Summit Hotel Properties
INN
$748M
| $1.45M | ﹤0.01% |
222,600
+41,000
| +23% | +$271K |
|
|
RPC
2208
Ridgepost Capital
RPC
$999M
| $1.45M | ﹤0.01% |
127,900
+17,900
| +16% | +$190K |
|
|
TWKS
2209
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.44M | ﹤0.01% |
191,200
+10,900
| +6% | +$80.6K |
|
2210
Invesco S&P 500 Quality ETF
SPHQ
$19.5B
| $1.44M | ﹤0.01% |
+28,500
| New | +$1.37M |
|
2211
CNA Financial
CNA
$14.6B
| $1.44M | ﹤0.01% |
37,200
+4,500
| +14% | +$175K |
|
2212
Apyx Medical
APYX
$177M
| $1.44M | ﹤0.01% |
285,495
-45,600
| -14% | -$231K |
|
2213
Brinker International
EAT
$9.51B
| $1.44M | ﹤0.01% |
+39,200
| New | +$1.48M |
|
2214
Forum Energy Technologies
FET
$779M
| $1.44M | ﹤0.01% |
56,063
-19,812
| -26% | -$469K |
|
2215
Identive
INVE
$64.3M
| $1.43M | ﹤0.01% |
170,282
+2,430
| +1% | +$16.6K |
|
2216
iShares MSCI World ETF
URTH
$8.07B
| $1.43M | ﹤0.01% |
+11,500
| New | +$1.38M |
|
2217
Globalstar
GSAT
$10.9B
| $1.43M | ﹤0.01% |
88,225
+73,931
| +517% | +$1.19M |
|
|
GTHX
2218
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.42M | ﹤0.01% |
571,791
+128,816
| +29% | +$352K |
|
2219
Esquire Financial Holdings
ESQ
$1.14B
| $1.42M | ﹤0.01% |
31,100
-29,400
| -49% | -$1.21M |
|
2220
C4 Therapeutics
CCCC
$383M
| $1.42M | ﹤0.01% |
516,898
+190,818
| +59% | +$613K |
|
2221
Cellebrite
CLBT
$3.73B
| $1.42M | ﹤0.01% |
197,300
+120,700
| +158% | +$704K |
|
2222
Lennar Class A
LEN
$20.2B
| $1.42M | ﹤0.01% |
+11,707
| New | +$1.28M |
|
|
FARM
2223
DELISTED
Farmer Brothers
FARM
| $1.42M | ﹤0.01% |
512,300
+32,900
| +7% | +$88.8K |
|
2224
Consensus Cloud Solutions
CCSI
$692M
| $1.42M | ﹤0.01% |
45,695
+30,495
| +201% | +$1.07M |
|
|
NIU
2225
Niu Technologies
NIU
$201M
| $1.41M | ﹤0.01% |
354,100
-72,000
| -17% | -$279K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.